Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Jaquenoud Sirot

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Therapeutic Drug Monitoring|July 2, 2004
Therapeutic monitoring of antidepressants in the era of pharmacogenetics studiesC B Eap, E Jaquenoud Sirot, P Baumann
Praxis|May 12, 2006
[Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry]P L Stephan, M Etzensberger, E Jaquenoud Sirot
Der Nervenarzt|September 28, 2004
[Why do schizophrenic patients smoke?]K Cattapan-Ludewig, S Ludewig, E Jaquenoud Sirot, et al.
Pharmacopsychiatry|July 28, 2006
Adverse drug reactions following nonresponse in a depressed patient with CYP2D6 deficiency and low CYP 3A4/5 activityP L Stephan, E Jaquenoud Sirot, B Mueller, et al.
Pharmacopsychiatry|November 17, 2011
Coprescription of levodopa with antipsychotics in a population of 84,596 psychiatric inpatients from 1994 to 2008P Haueis, S Russmann, O I Zorina, et al.
Journal of Clinical Psychopharmacology|June 23, 2004
Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 geneChin B Eap, Stefan Bender, E Jaquenoud Sirot, et al.
Pharmacopsychiatry|November 5, 2011
AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pharmacopsychiatry|October 5, 2011
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Therapeutic Drug Monitoring|July 2, 2004
Therapeutic monitoring of antidepressants in the era of pharmacogenetics studiesC B Eap, E Jaquenoud Sirot, P Baumann
Praxis|May 12, 2006
[Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry]P L Stephan, M Etzensberger, E Jaquenoud Sirot
Der Nervenarzt|September 28, 2004
[Why do schizophrenic patients smoke?]K Cattapan-Ludewig, S Ludewig, E Jaquenoud Sirot, et al.
Pharmacopsychiatry|July 28, 2006
Adverse drug reactions following nonresponse in a depressed patient with CYP2D6 deficiency and low CYP 3A4/5 activityP L Stephan, E Jaquenoud Sirot, B Mueller, et al.
Pharmacopsychiatry|November 17, 2011
Coprescription of levodopa with antipsychotics in a population of 84,596 psychiatric inpatients from 1994 to 2008P Haueis, S Russmann, O I Zorina, et al.
Journal of Clinical Psychopharmacology|June 23, 2004
Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 geneChin B Eap, Stefan Bender, E Jaquenoud Sirot, et al.
Pharmacopsychiatry|November 5, 2011
AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pharmacopsychiatry|October 5, 2011
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pageof 1